ALBIREO PHARMA, INC. (NASDAQ:ALBO) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
On March 14, 2017, Albireo Pharma, Inc. issued a press release
announcing its financial results for the year ended December 31,
2016. The full text of the press release is furnished as Exhibit
99.1 to this Current Report on Form 8-K.
The information in this Current Report on Form 8-K (including
Exhibit 99.1) shall not be deemed to be filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended
(the Exchange Act), or otherwise subject to the liabilities of
that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference
in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits
The following exhibit is furnished with this report:
|
Exhibit Number |
Description |
|
99.1 |
Press release dated March 14, 2017 |
ALBIREO PHARMA, INC. (NASDAQ:ALBO) Recent Trading Information
ALBIREO PHARMA, INC. (NASDAQ:ALBO) closed its last trading session up +0.09 at 25.19 with 9,171 shares trading hands.
